C50.A

Clinical Causes: Genetic mutations in breast tissue cells that lead to uncontrolled growth Changes or abnormalities in breast blood vessels and lymphatic pathways Inflammatory processes involving immune system response, though exact causes are unknown Environmental factors or genetic predispositions that increase risk

Key Symptoms: Rapid swelling and enlargement of one breast Redness covering most or all of the breast, often described as skin resembling an orange peel (peau d'orange) Tenderness or discomfort in the affected breast Warmth or localized feeling of heat in the breast Persistent breast pain that may not respond to usual treatments Possible nipple retraction or inversion Palpable thickening of the skin or breast tissue General feeling of illness or malaise in some cases

Diagnosis Path: Diagnosing inflammatory breast cancer involves a combination of methods: - **Medical history and physical examination:** Noting the rapid onset of symptoms, skin changes, and other physical findings. - **Imaging tests:** Breast mammography and ultrasound to visualize changes and rule out other conditions. - **Biopsy:** A tissue sample taken from the affected area to confirm malignancy and identify the specific cancer type. - **Additional tests:** MRI or PET scans may be conducted to assess the extent of disease spread. Early diagnosis is crucial to improving outcomes, as IBC can spread quickly and requires prompt treatment.

Treatment Protocols: Treatment of inflammatory breast cancer typically involves a comprehensive approach, including: - **Chemotherapy:** Often administered first to shrink the tumor and address potential spread. - **Surgery:** Usually a mastectomy (removal of the entire breast) to remove the affected tissue. - **Radiation therapy:** Used post-surgery to eliminate remaining cancer cells and reduce recurrence risk. - **Targeted therapy and hormonal therapy:** Based on specific characteristics of the tumor, such as hormone receptor status. - **Supportive care:** Managing symptoms, side effects, and emotional support throughout treatment. Since IBC is aggressive, a multidisciplinary team of oncologists, surgeons, and other specialists is essential in developing an effective treatment plan.